Eczematous drug eruption (Q91670): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Erupções por drogas são raramente de caráter eczematoso e um diagnóstico de erupção eczematosa por droga deve ser feito somente quando há evidência convincente de que o eczema está associado à exposição a droga. Pode ocorrer como resultado de sensibilização tópica prévia a um alérgeno contido na droga ou por meio de reação cruzada com um componente presente em medicamento administrado de forma sistêmica (dermatite de contato alérgica sistêmica). | |||
| description / en | description / en | ||
Drug eruptions are rarely eczematous in nature and a diagnosis of eczematous drug eruption should be made only when there is convincing evidence that the eczema is related to drug exposure. They may occur as a result of prior topical sensitization to an allergen contained in or which cross reacts with a compound present in a medication administered systemically (systemic allergic contact dermatitis). | |||
Revision as of 18:42, 15 August 2026
Drug eruptions are rarely eczematous in nature and a diagnosis of eczematous drug eruption should be made only when there is convincing evidence that the eczema is related to drug exposure. They may occur as a result of prior topical sensitization to an allergen contained in or which cross reacts with a compound present in a medication administered systemically (systemic allergic contact dermatitis).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_715259533 |
||
| English | Eczematous drug eruption |
Drug eruptions are rarely eczematous in nature and a diagnosis of eczematous drug eruption should be made only when there is convincing evidence that the eczema is related to drug exposure. They may occur as a result of prior topical sensitization to an allergen contained in or which cross reacts with a compound present in a medication administered systemically (systemic allergic contact dermatitis). |
